GSK3810109A
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK3810109A, covering 2023-11-18 to 2023-11-18. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Antiviral Effect, Safety and Tolerability of GSK3810109A in Viremic Human Immunodeficiency Virus (HIV)-1 Infected Adults [Phase 2]